{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:37:33Z","timestamp":1793317053587,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG072959"],"award-info":[{"award-number":["P30AG072959"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG065240"],"award-info":[{"award-number":["R01AG065240"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018576","name":"Harrington Discovery Institute, University Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mitochondrial dysfunction and \u03b1-Synuclein (\u03b1Syn) aggregation are defining features of Parkinson\u2019s disease (PD), yet the mechanistic link between them remains poorly understood. Although our previous findings suggest that the interaction between \u03b1Syn and ClpP (a mitochondrial matrix protease) contributes to PD progression, the pathogenic and therapeutic relevance of this interaction remains elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We employed biochemical and cell biological approaches to investigate how \u03b1Syn and ClpP are mutually regulated. Additionally, we determined the pathogenic impact of \u03b1Syn\u2013ClpP interaction by using decoy peptide CS2 in \u03b1Syn-PFF inoculated primary neurons, PD patient iPSC-derived dopaminergic neurons, and a transgenic mouse model of PD carrying \u03b1Syn-A53T mutation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified mitochondrial protease ClpP as a key regulator of \u03b1Syn pathology. We show that \u03b1Syn interacts with ClpP through its non-amyloid-\u03b2 component (NAC) domain, leading to impaired ClpP activity and mitochondrial proteotoxic stress. ClpP, in turn, negatively regulates \u03b1Syn aggregation and propagation by stabilizing its native tetrameric form. To interrupt this pathogenic interaction, we developed a decoy peptide, CS2, which binds the NAC domain of \u03b1Syn and restores ClpP function. CS2 treatment reduced mitochondrial oxidative stress and \u03b1Syn neurotoxicity in neuronal cultures, primary cortical neurons inoculated with \u03b1Syn preformed fibrils, and dopaminergic neurons derived from PD patient iPSCs. In mThy1-hSNCA transgenic mice, subcutaneous administration of CS2 restored ClpP levels, decreased \u03b1Syn pathology and neuroinflammation, and improved both cognitive and motor function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings highlight the \u03b1Syn\u2013ClpP interaction as a druggable target and support CS2 as a potential disease-modifying therapy for PD and related synucleinopathies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-025-00918-w","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T17:17:12Z","timestamp":1766423832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Disrupting \u03b1-Synuclein\u2013ClpP interaction restores mitochondrial function and attenuates neuropathology in Parkinson\u2019s disease models"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4047-7340","authenticated-orcid":false,"given":"Di","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9578-3890","authenticated-orcid":false,"given":"Xin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"918_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41572-021-00292-z","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D. Author correction: Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7:53.","journal-title":"Nat Rev Dis Primers"},{"key":"918_CR2","doi-asserted-by":"publisher","first-page":"10813","DOI":"10.1073\/pnas.152339799","volume":"99","author":"C Lo Bianco","year":"2002","unstructured":"Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P. Alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2002;99:10813\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"918_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","volume":"24","author":"HE Moon","year":"2015","unstructured":"Moon HE, Paek SH. Mitochondrial dysfunction in parkinson\u2019s disease. Exp Neurobiol. 2015;24:103\u201316.","journal-title":"Exp Neurobiol"},{"key":"918_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich MT, Oertel WH, Surmeier DJ, Geibl FF. Mitochondrial dysfunction in parkinson\u2019s disease - a key disease hallmark with therapeutic potential. Mol Neurodegener. 2023;18:83.","journal-title":"Mol Neurodegener"},{"key":"918_CR5","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1074\/jbc.M710012200","volume":"283","author":"L Devi","year":"2008","unstructured":"Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem. 2008;283:9089\u2013100.","journal-title":"J Biol Chem"},{"key":"918_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106\u2013107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet MF. Mitochondrial dysfunction and oxidative stress in parkinson\u2019s disease. Prog Neurobiol. 2013;106\u2013107:17\u201332.","journal-title":"Prog Neurobiol"},{"key":"918_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40478-019-0696-4","volume":"7","author":"X Wang","year":"2019","unstructured":"Wang X, Becker K, Levine N, Zhang M, Lieberman AP, Moore DJ, Ma J. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Acta Neuropathol Commun. 2019;7:41.","journal-title":"Acta Neuropathol Commun"},{"key":"918_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fnagi.2020.00100","volume":"12","author":"A Scorziello","year":"2020","unstructured":"Scorziello A, Borzacchiello D, Sisalli MJ, Di Martino R, Morelli M, Feliciello A. Mitochondrial homeostasis and signaling in Parkinson\u2019s disease. Front Aging Neurosci. 2020;12:100.","journal-title":"Front Aging Neurosci"},{"key":"918_CR9","doi-asserted-by":"crossref","unstructured":"Cilleros-Holgado P, Gomez-Fernandez D, Pinero-Perez R, Romero-Dominguez JM, Reche-Lopez D, Lopez-Cabrera A, Alvarez-Cordoba M, Munuera-Cabeza M, Talaveron-Rey M, Suarez-Carrillo A et al. Mitochondrial quality control via mitochondrial unfolded protein response (mtUPR) in ageing and neurodegenerative diseases. Biomolecules. 2023;13.","DOI":"10.3390\/biom13121789"},{"key":"918_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41419-020-03062-z","volume":"11","author":"K Nouri","year":"2020","unstructured":"Nouri K, Feng Y, Schimmer AD. Mitochondrial ClpP Serine protease-biological function and emerging target for cancer therapy. Cell Death Dis. 2020;11:841.","journal-title":"Cell Death Dis"},{"key":"918_CR11","doi-asserted-by":"crossref","unstructured":"Feng Y, Nouri K, Schimmer AD. Mitochondrial ATP-dependent proteases-biological function and potential anti-cancer targets. Cancers (Basel) 2021;13.","DOI":"10.3390\/cancers13092020"},{"key":"918_CR12","doi-asserted-by":"publisher","first-page":"e12912","DOI":"10.1111\/acel.12912","volume":"18","author":"S Jiang","year":"2019","unstructured":"Jiang S, Shao C, Tang F, Wang W, Zhu X. Dynamin-like protein 1 cleavage by Calpain in alzheimer\u2019s disease. Aging Cell. 2019;18:e12912.","journal-title":"Aging Cell"},{"key":"918_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.stem.2011.01.013","volume":"8","author":"HN Nguyen","year":"2011","unstructured":"Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, Gujar P, Kee K, Schule B, Dolmetsch RE, Langston W, et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell. 2011;8:267\u201380.","journal-title":"Cell Stem Cell"},{"key":"918_CR14","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1093\/hmg\/ddt301","volume":"22","author":"YC Su","year":"2013","unstructured":"Su YC, Qi X. Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation. Hum Mol Genet. 2013;22:4545\u201361.","journal-title":"Hum Mol Genet"},{"key":"918_CR15","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s44321-024-00083-5","volume":"16","author":"L de Boni","year":"2024","unstructured":"de Boni L, Wallis A, Hays Watson A, Ruiz-Riquelme A, Leyland LA, Bourinaris T, Hannaway N, Wullner U, Peters O, Priller J, et al. Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of parkinson\u2019s patients. EMBO Mol Med. 2024;16:1657\u201374.","journal-title":"EMBO Mol Med"},{"key":"918_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ. alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature. 2011;477:107\u201310.","journal-title":"Nature"},{"key":"918_CR17","doi-asserted-by":"publisher","first-page":"17797","DOI":"10.1073\/pnas.1113260108","volume":"108","author":"W Wang","year":"2011","unstructured":"Wang W, Perovic I, Chittuluru J, Kaganovich A, Nguyen LT, Liao J, Auclair JR, Johnson D, Landeru A, Simorellis AK, et al. A soluble alpha-synuclein construct forms a dynamic tetramer. Proc Natl Acad Sci U S A. 2011;108:17797\u2013802.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"918_CR18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ccell.2015.05.004","volume":"27","author":"A Cole","year":"2015","unstructured":"Cole A, Wang Z, Coyaud E, Voisin V, Gronda M, Jitkova Y, Mattson R, Hurren R, Babovic S, Maclean N, et al. Inhibition of the mitochondrial protease ClpP as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell. 2015;27:864\u201376.","journal-title":"Cancer Cell"},{"key":"918_CR19","doi-asserted-by":"publisher","first-page":"7314","DOI":"10.1038\/ncomms8314","volume":"6","author":"U Dettmer","year":"2015","unstructured":"Dettmer U, Newman AJ, Soldner F, Luth ES, Kim NC, von Saucken VE, Sanderson JB, Jaenisch R, Bartels T, Selkoe D. Parkinson-causing alpha-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun. 2015;6:7314.","journal-title":"Nat Commun"},{"key":"918_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2018.09.014","volume":"100","author":"S Nuber","year":"2018","unstructured":"Nuber S, Rajsombath M, Minakaki G, Winkler J, Muller CP, Ericsson M, Caldarone B, Dettmer U, Selkoe DJ. Abrogating native alpha-Synuclein tetramers in mice causes a L-DOPA-Responsive motor syndrome closely resembling parkinson\u2019s disease. Neuron. 2018;100:75\u2013e9075.","journal-title":"Neuron"},{"key":"918_CR21","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/jnc.15147","volume":"157","author":"B Frey","year":"2021","unstructured":"Frey B, AlOkda A, Jackson MP, Riguet N, Duce JA, Lashuel HA. Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: what you see is not always what you get. J Neurochem. 2021;157:872\u201388.","journal-title":"J Neurochem"},{"key":"918_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41598-021-04131-9","volume":"12","author":"M Hideshima","year":"2022","unstructured":"Hideshima M, Kimura Y, Aguirre C, Kakuda K, Takeuchi T, Choong CJ, Doi J, Nabekura K, Yamaguchi K, Nakajima K, et al. Two-step screening method to identify alpha-synuclein aggregation inhibitors for parkinson\u2019s disease. Sci Rep. 2022;12:351.","journal-title":"Sci Rep"},{"key":"918_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/13506129.2018.1517736","volume":"25","author":"A Sidhu","year":"2018","unstructured":"Sidhu A, Vaneyck J, Blum C, Segers-Nolten I, Subramaniam V. Polymorph-specific distribution of binding sites determines thioflavin-T fluorescence intensity in alpha-synuclein fibrils. Amyloid. 2018;25:189\u201396.","journal-title":"Amyloid"},{"key":"918_CR24","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","volume":"25","author":"ML Choi","year":"2022","unstructured":"Choi ML, Chappard A, Singh BP, Maclachlan C, Rodrigues M, Fedotova EI, Berezhnov AV, De S, Peddie CJ, Athauda D, et al. Pathological structural conversion of alpha-synuclein at the mitochondria induces neuronal toxicity. Nat Neurosci. 2022;25:1134\u201348.","journal-title":"Nat Neurosci"},{"key":"918_CR25","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1016\/j.febslet.2007.04.076","volume":"581","author":"AY Yu","year":"2007","unstructured":"Yu AY, Houry WA. ClpP: a distinctive family of cylindrical energy-dependent Serine proteases. FEBS Lett. 2007;581:3749\u201357.","journal-title":"FEBS Lett"},{"key":"918_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","volume":"1822","author":"L Breydo","year":"2012","unstructured":"Breydo L, Wu JW, Uversky VN. Alpha-synuclein misfolding and parkinson\u2019s disease. Biochim Biophys Acta. 2012;1822:261\u201385.","journal-title":"Biochim Biophys Acta"},{"key":"918_CR27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1073\/pnas.92.2.492","volume":"92","author":"D Ron","year":"1995","unstructured":"Ron D, Mochly-Rosen D. An autoregulatory region in protein kinase C: the pseudoanchoring site. Proc Natl Acad Sci U S A. 1995;92:492\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"918_CR28","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/j.ddmec.2010.07.001","volume":"7","author":"N Qvit","year":"2010","unstructured":"Qvit N, Mochly-Rosen D. Highly specific modulators of protein kinase C localization: applications to heart failure. Drug Discov Today Dis Mech. 2010;7:e87\u201393.","journal-title":"Drug Discov Today Dis Mech"},{"key":"918_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nbt1098-919","volume":"16","author":"MC Souroujon","year":"1998","unstructured":"Souroujon MC, Mochly-Rosen D. Peptide modulators of protein-protein interactions in intracellular signaling. Nat Biotechnol. 1998;16:919\u201324.","journal-title":"Nat Biotechnol"},{"key":"918_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.phrs.2007.04.014","volume":"55","author":"V Kheifets","year":"2007","unstructured":"Kheifets V, Mochly-Rosen D. Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function. Pharmacol Res. 2007;55:467\u201376.","journal-title":"Pharmacol Res"},{"key":"918_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.tem.2008.10.002","volume":"20","author":"EN Churchill","year":"2009","unstructured":"Churchill EN, Qvit N, Mochly-Rosen D. Rationally designed peptide regulators of protein kinase C. Trends Endocrinol Metab. 2009;20:25\u201333.","journal-title":"Trends Endocrinol Metab"},{"key":"918_CR32","doi-asserted-by":"publisher","first-page":"12646","DOI":"10.1038\/ncomms12646","volume":"7","author":"X Guo","year":"2016","unstructured":"Guo X, Sun X, Hu D, Wang YJ, Fujioka H, Vyas R, Chakrapani S, Joshi AU, Luo Y, Mochly-Rosen D, Qi X. VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of huntington\u2019s disease. Nat Commun. 2016;7:12646.","journal-title":"Nat Commun"},{"key":"918_CR33","first-page":"789","volume":"126","author":"X Qi","year":"2013","unstructured":"Qi X, Qvit N, Su YC, Mochly-Rosen D. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J Cell Sci. 2013;126:789\u2013802.","journal-title":"J Cell Sci"},{"key":"918_CR34","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s41467-019-09291-x","volume":"10","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Sun X, Hu D, Prosdocimo DA, Hoppel C, Jain MK, Ramachandran R, Qi X. ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects. Nat Commun. 2019;10:1371.","journal-title":"Nat Commun"},{"key":"918_CR35","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1172\/JCI70911","volume":"123","author":"X Guo","year":"2013","unstructured":"Guo X, Disatnik MH, Monbureau M, Shamloo M, Mochly-Rosen D, Qi X. Inhibition of mitochondrial fragmentation diminishes huntington\u2019s disease-associated neurodegeneration. J Clin Invest. 2013;123:5371\u201388.","journal-title":"J Clin Invest"},{"key":"918_CR36","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41467-022-28769-9","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Hu D, Wang R, Sun X, Ropelewski P, Hubler Z, Lundberg K, Wang Q, Adams DJ, Xu R, Qi X. ATAD3A oligomerization promotes neuropathology and cognitive deficits in alzheimer\u2019s disease models. Nat Commun. 2022;13:1121.","journal-title":"Nat Commun"},{"key":"918_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1042\/BJ20131438","volume":"461","author":"X Guo","year":"2014","unstructured":"Guo X, Sesaki H, Qi X. Drp1 stabilizes p53 on the mitochondria to trigger necrosis under oxidative stress conditions in vitro and in vivo. Biochem J. 2014;461:137\u201346.","journal-title":"Biochem J"},{"key":"918_CR38","doi-asserted-by":"publisher","first-page":"e000461","DOI":"10.1161\/JAHA.113.000461","volume":"2","author":"MH Disatnik","year":"2013","unstructured":"Disatnik MH, Ferreira JC, Campos JC, Gomes KS, Dourado PM, Qi X, Mochly-Rosen D. Acute Inhibition of excessive mitochondrial fission after myocardial infarction prevents long-term cardiac dysfunction. J Am Heart Assoc. 2013;2:e000461.","journal-title":"J Am Heart Assoc"},{"key":"918_CR39","doi-asserted-by":"publisher","first-page":"32656","DOI":"10.1038\/srep32656","volume":"6","author":"E Filichia","year":"2016","unstructured":"Filichia E, Hoffer B, Qi X, Luo Y. Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a parkinson\u2019s disease model induced by MPTP. Sci Rep. 2016;6:32656.","journal-title":"Sci Rep"},{"key":"918_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.expneurol.2017.02.015","volume":"292","author":"F Luo","year":"2017","unstructured":"Luo F, Herrup K, Qi X, Yang Y. Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis. Exp Neurol. 2017;292:21\u201334.","journal-title":"Exp Neurol"},{"key":"918_CR41","doi-asserted-by":"publisher","first-page":"101715","DOI":"10.1016\/j.xcrm.2024.101715","volume":"5","author":"PS Sridharan","year":"2024","unstructured":"Sridharan PS, Koh Y, Miller E, Hu D, Chakraborty S, Tripathi SJ, Kee TR, Chaubey K, Vazquez-Rosa E, Barker S, et al. Acutely blocking excessive mitochondrial fission prevents chronic neurodegeneration after traumatic brain injury. Cell Rep Med. 2024;5:101715.","journal-title":"Cell Rep Med"},{"key":"918_CR42","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0196-8858(91)90017-D","volume":"12","author":"XQM Huang","year":"1991","unstructured":"Huang XQM, Time-Efficient WA. Linear-Space local similarity algorithm. Adv Appl Math. 1991;12:337\u201357.","journal-title":"Adv Appl Math"},{"key":"918_CR43","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1091\/mbc.e10-06-0551","volume":"22","author":"X Qi","year":"2011","unstructured":"Qi X, Disatnik MH, Shen N, Sobel RA, Mochly-Rosen D. Aberrant mitochondrial fission in neurons induced by protein kinase C{delta} under oxidative stress conditions in vivo. Mol Biol Cell. 2011;22:256\u201365.","journal-title":"Mol Biol Cell"},{"key":"918_CR44","first-page":"173","volume":"118","author":"X Qi","year":"2008","unstructured":"Qi X, Inagaki K, Sobel RA, Mochly-Rosen D. Sustained Pharmacological Inhibition of deltapkc protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats. J Clin Investig. 2008;118:173\u201382.","journal-title":"J Clin Investig"},{"key":"918_CR45","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1242\/jcs.024653","volume":"121","author":"X Qi","year":"2008","unstructured":"Qi X, Mochly-Rosen D. The PKCdelta -Abl complex communicates ER stress to the mitochondria - an essential step in subsequent apoptosis. J Cell Sci. 2008;121:804\u201313.","journal-title":"J Cell Sci"},{"key":"918_CR46","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.yjmcc.2007.07.061","volume":"43","author":"X Qi","year":"2007","unstructured":"Qi X, Vallentin A, Churchill E, Mochly-Rosen D. DeltaPKC participates in the Endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart. J Mol Cell Cardiol. 2007;43:420\u20138.","journal-title":"J Mol Cell Cardiol"},{"key":"918_CR47","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley LA, Luk KC, Lee VM. Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to lewy body and lewy neurite-like aggregates. Nat Protoc. 2014;9:2135\u201346.","journal-title":"Nat Protoc"},{"key":"918_CR48","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.celrep.2014.05.033","volume":"7","author":"HT Tran","year":"2014","unstructured":"Tran HT, Chung CH, Iba M, Zhang B, Trojanowski JQ, Luk KC, Lee VM. Alpha-synuclein immunotherapy blocks uptake and templated propagation of misfolded alpha-synuclein and neurodegeneration. Cell Rep. 2014;7:2054\u201365.","journal-title":"Cell Rep"},{"key":"918_CR49","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1523\/JNEUROSCI.0060-19.2019","volume":"39","author":"Q Wu","year":"2019","unstructured":"Wu Q, Takano H, Riddle DM, Trojanowski JQ, Coulter DA, Lee VM. alpha-Synuclein (alphaSyn) preformed fibrils induce endogenous AlphaSyn Aggregation, compromise synaptic activity and enhance synapse loss in cultured excitatory hippocampal neurons. J Neurosci. 2019;39:5080\u201394.","journal-title":"J Neurosci"},{"key":"918_CR50","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00401-019-01993-2","volume":"137","author":"D Hu","year":"2019","unstructured":"Hu D, Sun X, Liao X, Zhang X, Zarabi S, Schimmer A, Hong Y, Ford C, Luo Y, Qi X. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Acta Neuropathol. 2019;137:939\u201360.","journal-title":"Acta Neuropathol"},{"key":"918_CR51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","volume":"240","author":"DG Walker","year":"2013","unstructured":"Walker DG, Lue LF, Adler CH, Shill HA, Caviness JN, Sabbagh MN, Akiyama H, Serrano GE, Sue LI, Beach TG. Arizona Parkinson disease C: changes in properties of Serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol. 2013;240:190\u2013204.","journal-title":"Exp Neurol"},{"key":"918_CR52","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1038\/srep05797","volume":"4","author":"JF Kellie","year":"2014","unstructured":"Kellie JF, Higgs RE, Ryder JW, Major A, Beach TG, Adler CH, Merchant K, Knierman MD. Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and parkinson\u2019s disease brain tissue by intact protein mass spectrometry. Sci Rep. 2014;4:5797.","journal-title":"Sci Rep"},{"key":"918_CR53","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4:160\u20134.","journal-title":"Nat Cell Biol"},{"key":"918_CR54","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41419-024-06630-9","volume":"15","author":"MI Oliveira da Silva","year":"2024","unstructured":"Oliveira da Silva MI, Santejo M, Babcock IW, Magalhaes A, Minamide LS, Won SJ, Castillo E, Gerhardt E, Fahlbusch C, Swanson RA, et al. alpha-Synuclein triggers Cofilin pathology and dendritic spine impairment via a PrP(C)-CCR5 dependent pathway. Cell Death Dis. 2024;15:264.","journal-title":"Cell Death Dis"},{"key":"918_CR55","doi-asserted-by":"publisher","first-page":"9754","DOI":"10.1523\/JNEUROSCI.0344-18.2018","volume":"38","author":"PJ Teravskis","year":"2018","unstructured":"Teravskis PJ, Covelo A, Miller EC, Singh B, Martell-Martinez HA, Benneyworth MA, Gallardo C, Oxnard BR, Araque A, Lee MK, Liao D. A53T mutant Alpha-Synuclein induces Tau-Dependent postsynaptic impairment independently of neurodegenerative changes. J Neurosci. 2018;38:9754\u201367.","journal-title":"J Neurosci"},{"key":"918_CR56","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","volume":"9","author":"MF Chesselet","year":"2012","unstructured":"Chesselet MF, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR. A progressive mouse model of parkinson\u2019s disease: the Thy1-aSyn (Line 61) mice. Neurotherapeutics. 2012;9:297\u2013314.","journal-title":"Neurotherapeutics"},{"key":"918_CR57","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, Zhang B, Yue Z. Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun. 2020;11:1386.","journal-title":"Nat Commun"},{"key":"918_CR58","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/acn3.257","volume":"2","author":"M Morris","year":"2015","unstructured":"Morris M, Sanchez PE, Verret L, Beagle AJ, Guo W, Dubal D, Ranasinghe KG, Koyama A, Ho K, Yu GQ, et al. Network dysfunction in alpha-synuclein Transgenic mice and human lewy body dementia. Ann Clin Transl Neurol. 2015;2:1012\u201328.","journal-title":"Ann Clin Transl Neurol"},{"key":"918_CR59","first-page":"1316","volume":"6","author":"MA Baptista","year":"2013","unstructured":"Baptista MA, Dave KD, Sheth NP, De Silva SN, Carlson KM, Aziz YN, Fiske BK, Sherer TB, Frasier MA. A strategy for the generation, characterization and distribution of animal models by the Michael J. Fox foundation for parkinson\u2019s research. Dis Model Mech. 2013;6:1316\u201324.","journal-title":"Dis Model Mech"},{"key":"918_CR60","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s12276-022-00895-w","volume":"54","author":"TK Kim","year":"2022","unstructured":"Kim TK, Bae EJ, Jung BC, Choi M, Shin SJ, Park SJ, Kim JT, Jung MK, Ulusoy A, Song MY, et al. Inflammation promotes synucleinopathy propagation. Exp Mol Med. 2022;54:2148\u201361.","journal-title":"Exp Mol Med"},{"key":"918_CR61","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22:657\u201373.","journal-title":"Nat Rev Immunol"},{"key":"918_CR62","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.15252\/embj.201694253","volume":"35","author":"K Szczepanowska","year":"2016","unstructured":"Szczepanowska K, Maiti P, Kukat A, Hofsetz E, Nolte H, Senft K, Becker C, Ruzzenente B, Hornig-Do HT, Wibom R, et al. CLPP coordinates mitoribosomal assembly through the regulation of ERAL1 levels. EMBO J. 2016;35:2566\u201383.","journal-title":"EMBO J"},{"key":"918_CR63","doi-asserted-by":"publisher","first-page":"18375","DOI":"10.1038\/srep18375","volume":"5","author":"F Fischer","year":"2015","unstructured":"Fischer F, Langer JD, Osiewacz HD. Identification of potential mitochondrial CLPXP protease interactors and substrates suggests its central role in energy metabolism. Sci Rep. 2015;5:18375.","journal-title":"Sci Rep"},{"key":"918_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2018.04.018","volume":"651","author":"JH Martinez","year":"2018","unstructured":"Martinez JH, Fuentes F, Vanasco V, Alvarez S, Alaimo A, Cassina A, Coluccio Leskow F, Velazquez F. Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment. Arch Biochem Biophys. 2018;651:1\u201312.","journal-title":"Arch Biochem Biophys"},{"key":"918_CR65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.brainres.2008.08.067","volume":"1244","author":"L Zhang","year":"2008","unstructured":"Zhang L, Zhang C, Zhu Y, Cai Q, Chan P, Ueda K, Yu S, Yang H. Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: an Immunogold electron microscopic study using a C-terminal specific monoclonal antibody. Brain Res. 2008;1244:40\u201352.","journal-title":"Brain Res"},{"key":"918_CR66","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41531-024-00733-y","volume":"10","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ruan L, Wang H, Zhu J, Li T, Sun G, Dong Y, Wang Y, Berreby G, Shay A, et al. Enhancing mitochondrial proteolysis alleviates alpha-synuclein-mediated cellular toxicity. NPJ Parkinsons Dis. 2024;10:120.","journal-title":"NPJ Parkinsons Dis"},{"key":"918_CR67","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3389\/fneur.2018.00711","volume":"9","author":"M Muthuraman","year":"2018","unstructured":"Muthuraman M, Koirala N, Ciolac D, Pintea B, Glaser M, Groppa S, Tamas G, Groppa S. Deep brain stimulation and L-DOPA therapy: concepts of action and clinical applications in parkinson\u2019s disease. Front Neurol. 2018;9:711.","journal-title":"Front Neurol"},{"key":"918_CR68","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P. Signaling pathways in parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:73.","journal-title":"Signal Transduct Target Ther"},{"key":"918_CR69","doi-asserted-by":"publisher","first-page":"18467","DOI":"10.1074\/jbc.M115.641746","volume":"290","author":"TK Rostovtseva","year":"2015","unstructured":"Rostovtseva TK, Gurnev PA, Protchenko O, Hoogerheide DP, Yap TL, Philpott CC, Lee JC, Bezrukov SM. alpha-Synuclein shows high affinity interaction with Voltage-dependent anion Channel, suggesting mechanisms of mitochondrial regulation and toxicity in Parkinson disease. J Biol Chem. 2015;290:18467\u201377.","journal-title":"J Biol Chem"},{"key":"918_CR70","doi-asserted-by":"publisher","first-page":"183643","DOI":"10.1016\/j.bbamem.2021.183643","volume":"1863","author":"DP Hoogerheide","year":"2021","unstructured":"Hoogerheide DP, Rostovtseva TK, Bezrukov SM. Exploring lipid-dependent conformations of membrane-bound alpha-synuclein with the VDAC nanopore. Biochim Biophys Acta Biomembr. 2021;1863:183643.","journal-title":"Biochim Biophys Acta Biomembr"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00918-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00918-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00918-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:02:56Z","timestamp":1767045776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-025-00918-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00918-w","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with protocols approved by the Institutional Animal Care and Use Committee of Case Western Reserve University and were performed based on the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Sufficient procedures were employed for reduction of pain or discomfort of subjects during the experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A provisional patent on the development and application of CS2 peptide has been filed at Case Western Reserve University.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}